- Home
- GBLI vs FLGT Comparison
GBLI vs FLGT Comparison
Compare GBLI & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBLI
- FLGT
- Stock Information
- Founded
- GBLI 2016
- FLGT 2011
- Country
- GBLI United States
- FLGT United States
- Employees
- GBLI N/A
- FLGT N/A
- Industry
- GBLI Property-Casualty Insurers
- FLGT Medical Specialities
- Sector
- GBLI Finance
- FLGT Health Care
- Exchange
- GBLI Nasdaq
- FLGT Nasdaq
- Market Cap
- GBLI 476.1M
- FLGT 508.7M
- IPO Year
- GBLI 2003
- FLGT 2016
- Fundamental
- Price
- GBLI $34.95
- FLGT $17.62
- Analyst Decision
- GBLI
- FLGT Hold
- Analyst Count
- GBLI 0
- FLGT 1
- Target Price
- GBLI N/A
- FLGT $16.00
- AVG Volume (30 Days)
- GBLI 5.4K
- FLGT 727.9K
- Earning Date
- GBLI 05-07-2025
- FLGT 05-02-2025
- Dividend Yield
- GBLI 4.07%
- FLGT N/A
- EPS Growth
- GBLI 70.49
- FLGT N/A
- EPS
- GBLI 3.12
- FLGT N/A
- Revenue
- GBLI $441,087,000.00
- FLGT $283,470,000.00
- Revenue This Year
- GBLI $8.70
- FLGT $11.70
- Revenue Next Year
- GBLI $14.56
- FLGT $9.90
- P/E Ratio
- GBLI $11.03
- FLGT N/A
- Revenue Growth
- GBLI N/A
- FLGT N/A
- 52 Week Low
- GBLI $29.65
- FLGT $14.57
- 52 Week High
- GBLI $37.00
- FLGT $25.11
- Technical
- Relative Strength Index (RSI)
- GBLI 45.98
- FLGT 57.62
- Support Level
- GBLI $34.20
- FLGT $16.51
- Resistance Level
- GBLI $34.95
- FLGT $17.20
- Average True Range (ATR)
- GBLI 0.66
- FLGT 0.56
- MACD
- GBLI -0.15
- FLGT 0.04
- Stochastic Oscillator
- GBLI 26.81
- FLGT 98.23
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. The company's three primary segments are Commercial Specialty, Reinsurance operations, and Exited Lines. The majority of its revenue is from the Commercial Specialty segment. Geographically, the majority is from California.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.